Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas T Rissanen

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007
Current status of cardiovascular gene therapyTuomas T Rissanen, Seppo Ylä-Herttuala
Frontiers in Cardiovascular Medicine|February 16, 2026
Safety and feasibility of the treatment of calcified <i>de novo</i> coronary artery lesions with drug-coated balloon angioplasty after intravascular lithotripsyAlma Räsänen, Antti Eranti, Tuomas T Rissanen
Advances in Genetics|November 4, 2004
Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemiaTuomas T Rissanen, Juha Rutanen, Seppo Ylä-Herttuala
Frontiers in Cardiovascular Medicine|November 17, 2022
Technical success, clinical efficacy, and insight into the causes of restenosis after the percutaneous coronary intervention of <i>de novo</i> coronary artery lesions using a paclitaxel-coated balloon with citrate ester excipientJerry Tervo, Jussi M Kärkkäinen, Tuomas T Rissanen
Trends in Cardiovascular Medicine|December 15, 2004
Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trialsSeppo Ylä-Herttuala, Johanna E Markkanen, Tuomas T Rissanen
Journal of the American College of Cardiology|March 14, 2007
Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicineSeppo Ylä-Herttuala, Tuomas T Rissanen, Ismo Vajanto, et al.
Frontiers of Medicine|December 23, 2022
Drug-coated balloon-only strategy for percutaneous coronary intervention of de novo left main coronary artery disease: the importance of proper lesion preparationSanna Uskela, Antti Eranti, Jussi M Kärkkäinen, et al.
Cardiovascular Research|January 25, 2005
Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart--gene therapyJohanna E Markkanen, Tuomas T Rissanen, Antti Kivelä, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2023
Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel conceptAlma Räsänen, Jussi M Kärkkäinen, Antti Eranti, et al.
Radiation Protection Dosimetry|August 31, 2024
Implantation of CRT pacemaker during pregnancy: estimated fetal radiation doseAnna-Leena Manninen, Jukka Järvinen, Joanna Sierpowska, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007
Current status of cardiovascular gene therapyTuomas T Rissanen, Seppo Ylä-Herttuala
Frontiers in Cardiovascular Medicine|February 16, 2026
Safety and feasibility of the treatment of calcified <i>de novo</i> coronary artery lesions with drug-coated balloon angioplasty after intravascular lithotripsyAlma Räsänen, Antti Eranti, Tuomas T Rissanen
Advances in Genetics|November 4, 2004
Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemiaTuomas T Rissanen, Juha Rutanen, Seppo Ylä-Herttuala
Frontiers in Cardiovascular Medicine|November 17, 2022
Technical success, clinical efficacy, and insight into the causes of restenosis after the percutaneous coronary intervention of <i>de novo</i> coronary artery lesions using a paclitaxel-coated balloon with citrate ester excipientJerry Tervo, Jussi M Kärkkäinen, Tuomas T Rissanen
Trends in Cardiovascular Medicine|December 15, 2004
Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trialsSeppo Ylä-Herttuala, Johanna E Markkanen, Tuomas T Rissanen
Journal of the American College of Cardiology|March 14, 2007
Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicineSeppo Ylä-Herttuala, Tuomas T Rissanen, Ismo Vajanto, et al.
Frontiers of Medicine|December 23, 2022
Drug-coated balloon-only strategy for percutaneous coronary intervention of de novo left main coronary artery disease: the importance of proper lesion preparationSanna Uskela, Antti Eranti, Jussi M Kärkkäinen, et al.
Cardiovascular Research|January 25, 2005
Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart--gene therapyJohanna E Markkanen, Tuomas T Rissanen, Antti Kivelä, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2023
Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel conceptAlma Räsänen, Jussi M Kärkkäinen, Antti Eranti, et al.
Radiation Protection Dosimetry|August 31, 2024
Implantation of CRT pacemaker during pregnancy: estimated fetal radiation doseAnna-Leena Manninen, Jukka Järvinen, Joanna Sierpowska, et al.
Pageof 9